Textile-based prothesis for laparoscopic surgery

Information

  • Patent Grant
  • 11622845
  • Patent Number
    11,622,845
  • Date Filed
    Wednesday, July 31, 2019
    5 years ago
  • Date Issued
    Tuesday, April 11, 2023
    a year ago
Abstract
The invention relates to a prosthesis (1) comprising a textile (2) of elongate shape defining a longitudinal axis A, and a resilient frame (3) connected to said textile along substantially the peripheral edge of the textile, said frame forming, in the area of each short side of the textile, at least one U-shaped bend (4) extending in the direction of the longitudinal axis, said frame being able to adopt an unstressed configuration, in which said textile is deployed, and a stressed configuration, in which said frame is subjected to a radial force directed towards said longitudinal axis and said textile forms at least one longitudinal fold.
Description

The present invention relates to a prosthesis based on a biocompatible textile and more particularly intended to be implanted by laparoscopy, such as, for example, the wall reinforcement prostheses for repair of hernias.


Wall reinforcement prostheses, for example for the abdominal wall, are widely used in surgery. These prostheses are intended to treat hernias by temporarily or permanently filling a tissue defect. These prostheses are generally made from a biocompatible prosthetic textile and can have a number of shapes, for example rectangular, circular or oval, depending on the anatomical structure to which they are to adapt. Some of these prostheses are made from entirely bioresorbable filaments and are intended to disappear after they have performed their reinforcing function during the period of cellular colonization and tissue rehabilitation. Others comprise non-bioresorbable filaments and are intended to remain permanently in the body of the patient.


Moreover, in order to minimize the trauma subsequent to any surgical intervention, patients are increasingly operated on by laparoscopy when the type of intervention performed allows this. Laparoscopy requires only very small incisions through which a trocar is passed, with the prosthesis being conveyed inside the trocar to the implantation site. Open surgery is thus avoided, and the patient can soon leave hospital. Laparoscopy is particularly popular in surgical interventions performed in the abdomen, for example the treatment of hernias.


However, the trocars used in laparoscopic surgery generally have a relatively small calibrated diameter, which may vary, for example, from 5 to 15 mm, in order to reduce as much as possible the size of the incision that is made. The prosthesis therefore has to be conveyed within a conduit of small diameter and must then be deployed at the implantation site.


To carry out this step, the prosthesis is generally rolled up on itself in order to make it slide in the conduit of the trocar or is introduced directly by force. For this step, the surgeon generally uses laparoscopy forceps to push/guide the prosthesis inside the trocar. These forceps take up a lot of space in the trocar. The small diameter of the trocar makes this step particularly difficult to carry out. If the rolling-up of the prosthesis is not correctly guided and effected, the textile may form a plug in the trocar. The prosthesis no longer slides inside the trocar, and it is very complicated to remove it from the latter. Moreover, even when the prosthesis has been correctly rolled up, the emergence of the prosthesis from the trocar and the deployment of the prosthesis at the implantation site are complex steps. Indeed, the surgeon initially has to pull on the prosthesis in order to free it from the trocar, but without damaging it. He then has to deploy the prosthesis and spread the latter out perfectly. If the prosthesis does not spread out perfectly against the abdominal wall for example, there may be a risk of a soft organ being inserted between the prosthesis and said wall, which can lead to risks of adherence, pain and intestinal occlusion and can increase the possibility of recurrence. It is therefore essential for the surgeon to ensure that no part of the prosthesis is folded and that no viscera or part of the intestine is caught between the prosthesis and the abdominal wall. However, on account of the limited space at the implantation site, it may prove complicated to deploy the prosthesis and then to orient it suitably with respect to the surrounding anatomical structures.


There is therefore still the need for a prosthesis that is based on a biocompatible textile, that can be used for the repair of hernias, that can be easily introduced into a conduit such as that of a trocar of small diameter, without damaging said textile, and that is able to be deployed completely, and preferably easily, once the implantation site in the body of the patient has been reached.


The present invention aims to meet such a need.


A first aspect of the invention concerns a prosthesis comprising:


at least one flexible biocompatible textile of generally elongate shape defining a longitudinal axis, said textile being delimited by a peripheral outer edge forming substantially two opposite long sides and two opposite short sides, and


at least one reinforcing element for said textile,


characterized in that said reinforcing element is in the form of a resilient frame connected to said textile along substantially the peripheral edge of the textile, said frame forming, in the area of each short side of the textile, at least one U-shaped bend extending in the direction of the longitudinal axis, said frame being able to adopt an unstressed configuration, in which said textile is deployed, and a stressed configuration, in which said frame is subjected to a radial force directed towards said longitudinal axis and said textile forms at least one longitudinal fold.


The prosthesis according to the invention is able to be folded up along at least one longitudinal fold in a very simple way, for example by pressing the frame together, in one hand, radially in the direction of the longitudinal axis of the prosthesis. Thus, the prosthesis is capable of adopting an elongate configuration, which is very compact in the radial direction, allowing it to pass easily through a trocar, without the aid of additional tools. The frame is sufficiently resilient to allow the prosthesis to be folded in order to enter a trocar of small diameter, for example a diameter of 5 to 15 mm. When it emerges from the trocar, the prosthesis is then capable of deploying automatically under the action of the frame, which recovers its initial configuration in the absence of the stresses from the walls of the trocar. The prosthesis is capable of conforming to the anatomical structures and of remaining in place once it has emerged from the trocar.


According to the present invention, “textile” is understood as any arrangement or assembly of biocompatible yarns, fibres, filaments and/or multifilaments, for example obtained by knitting, weaving, braiding, or non-woven.


In the present application, “biocompatible” is understood as meaning that the materials having this property can be implanted in the human or animal body.


Within the meaning of the present application, a “flexible textile” is understood as a textile that can be folded up but that does not have an inherent elasticity allowing it to spontaneously recover a spread-out configuration once it has been folded up.


Within the meaning of the present application, a “resilient frame” is understood as a frame which, for example, can be semi-rigid and has a resiliency or elasticity allowing it to be deformed under the effect of a temporary stress and allowing it to return to an initial state of rest once said stress has been removed. According to the present invention, the frame allows the textile, and therefore the prosthesis, to be pressed together in the radial direction towards the longitudinal axis of the textile.


This step of pressing together is made easier by the presence of the U-shaped bends, which are disposed on the short sides of the frame and give the frame an additional elasticity. Thus, under the effect of the radial stress exerted on the long sides of the frame, the U-shaped bends form a hard point acting as a guide element aligned on the longitudinal axis of the prosthesis, making it easier to introduce the prosthesis into a trocar in the direction of the longitudinal axis of the prosthesis and of the trocar.


The materials that may be suitable for producing the frame of the prosthesis according to the invention may be chosen from any biocompatible material having a certain rigidity in order to meet the requirements described above.


In one embodiment, the frame is made of a bioresorbable material. In the present application, “bioresorbable” or “biodegradable” is understood to mean that the materials having this property are absorbed and/or degraded by the tissues or washed from the implantation site and disappear in vivo after a certain time, which may vary, for example, from a few hours to a few months, depending on the chemical nature of the materials.


Thus, the frame acts as a guide for the prosthesis for introducing the latter into a trocar, then acts as a means of stiffening the prosthesis during the positioning and implanting of the prosthesis, after which it gradually degrades when the textile has been recolonized by the surrounding cells.


For example, the bioresorbable material can be chosen from among polylactic acid (PLA), polycaprolactones (PCL), polydioxanones (PDO), trimethylene carbonates (TMC), polyvinyl alcohol (PVA), polyhydroxyalkanoates (PHA), oxidized cellulose, polyglycolic acid (PGA), copolymers of these materials and mixtures thereof. For example, the bioresorbable material can be a copolymer of polylactic acid and of polyglycolic acid.


Alternatively, the frame of the prosthesis according to the invention is made of a non-bioresorbable material chosen from among polypropylenes, polyesters such as polyethyleneterephthalates, polyamides, silicones, polyether ether ketone (PEEK), polyarylether ether ketone (PAEK), polyurethanes and mixtures thereof.


In another embodiment, said frame is formed by a combination of bioresorbable material and of non-bioresorbable material.


The frame of the prosthesis according to the invention substantially follows the peripheral edge of the textile, in other words it is substantially parallel to this edge, and can, for example, be set back from the peripheral outer edge of the textile. Thus, by adopting the shape of the contour of the textile, the frame can have an outer perimeter lower than that of the peripheral outer edge of the textile. In other words, the peripheral outer edge of the textile can extend beyond the frame by a certain distance. For example, this distance can be greater than or equal to 1 mm. In other words, the frame and the peripheral outer edge of the textile are of similar geometrical shape, but the frame can have smaller dimensions than those of the peripheral outer edge of the textile.


In one embodiment, for each short side, said U-shaped bend extends towards the outside of said frame. Thus, during the step of pressing together, each U-shaped bend forms a loop and therefore a hard point facilitating the introduction of the pressed-together prosthesis into a trocar of small diameter, for example a diameter of 5-15 mm. Then, when the prosthesis emerges from the trocar, the absence of stress exerted on the long sides of the frame allows the latter to redeploy naturally and automatically, and the textile recovers its initial spread-out configuration.


In one embodiment, for each short side, said U-shaped bend extends towards the inside of said frame. For example, the frame can form a supplementary bend in the area of each long side, said supplementary bend extending towards the inside of the frame in a direction perpendicular to the longitudinal axis A. Such a shape of the frame makes it possible to easily press the prosthesis together and align it on the longitudinal axis A. Since the U-shaped bend of each short side extends towards the inside of the frame, the step of pressing together causes the formation of two stubs at the ends of the pressed-together prosthesis, these two stubs making it easier to introduce the prosthesis into the trocar.


In one embodiment, said frame is continuous. Thus, the step of pressing the prosthesis together, by pressing the frame together towards the longitudinal axis of the prosthesis, does not create any projecting elements that could potentially perforate and damage the tissues. By virtue of its nature and its shape, the frame only has rounded and atraumatic outer contours.


The frame of the prosthesis according to the invention is connected to said textile. For example, the frame can be fixed to the textile by sewing, ultrasonic welding, or else by adhesive bonding or moulding.


In one embodiment, the frame of the prosthesis according to the invention is moulded over the textile. Thus, the frame is connected to the textile by injection moulding of one or more thermoplastic or thermosetting biocompatible materials. For example, the mould of an injection-moulding machine is equipped with an insert gate in which the textile is held. One or more thermoplastic or thermosetting biocompatible materials are then heated to their melting point and injected into the mould, the latter having one or more channels of the shape desired for the frame. The holding of the textile, the precision of the injection volume and the choice of the injection parameters make it possible to obtain a frame without material loss, without flash and with good surface evenness. Such a method allows the frame to be fixed to the textile in a particularly effective and lasting way.


In one embodiment, the frame is obtained by moulding a copolymer of polylactic acid and of polyglycolic acid over the textile.


The textile of the prosthesis according to the invention has a generally elongate shape, for example rectangular, oval or elliptic. The textile can have another initial shape and can then be cut to such an elongate shape, in particular to a shape adapted to the defect, for example the hernia defect, that is to be treated.


In one embodiment, said generally elongate shape is a rectangle. In another embodiment, said generally elongate shape is an ellipse. Such a shape is particularly advantageous, since it is similar to the anatomical shape of the defect that is to be filled. Moreover, when pressed together, such a prosthesis adopts a shape that is perfectly aligned on its longitudinal axis, permitting easier introduction into a trocar, even one of small diameter.


In one embodiment, the textile is a mesh.


Within the meaning of the present application, a “mesh” is understood as a textile, as defined above, which is openworked, that is to say provided with pores that favour recolonization of tissue. Such a mesh can be bioresorbable, permanent or partially bioresorbable. It is sufficiently flexible to be folded up at the time of introduction into the abdominal cavity. The mesh can be made from a layer of textile or several layers of textile. Such meshes are well known to a person skilled in the art.


In one embodiment of the invention, the mesh is a knit. By virtue of the meshwork of the knit, it is possible to obtain openworked faces that promote cell recolonization after implantation. The knit can be two-dimensional or three-dimensional.


Within the meaning of the present application, a two-dimensional knit is understood as a knit having two opposite faces linked to each other by meshes but devoid of a spacer giving it a certain thickness: such a knit can be obtained, for example, by knitting yarns on a warp knitting machine or raschel knitting machine using two guide bars. Examples of knitting two-dimensional knits suitable for the present invention are given in the document WO2009/071998.


According to the present application, a three-dimensional knit is understood as a knit having two opposite faces linked to each other by a spacer that gives the knit a significant thickness, said spacer itself being formed from additional linking yarns in addition to the yarns forming the two faces of the knit. Such a knit can be obtained, for example, on a double-bed warp knitting or raschel knitting machine using several guide bars. Examples of knitting three-dimensional knits suitable for the present invention are given in the documents WO99/05990, WO2009/031035 and WO2009/071998.


In one embodiment of the invention, one face of the textile is covered by a non-stick coating.


Such a non-stick coating makes it possible in particular to avoid the formation of undesired and serious post-surgical fibrous adhesions.


Within the meaning of the present application, “non-stick” is understood as a smooth and non-porous biocompatible material or coating that does not offer space for cell recolonization and that preferably promotes the growth of peritoneum.


Another aspect of the present invention is a method by which a prosthesis of the kind described above is conveyed to an implantation site, said method comprising the following steps:


the above prosthesis is pressed together in one hand, by folding the two long sides of the textile over towards the medial longitudinal axis of the prosthesis,


the longitudinal axis of the prosthesis, which has thereby been made compact, is lined up with the longitudinal axis of a trocar intended to receive said prosthesis,


said bend is introduced into the proximal orifice of the trocar, and the compact prosthesis is pushed through the inside of the trocar by a force directed along the longitudinal axis of the trocar.


The prosthesis is thus pushed along the longitudinal axis of the trocar until its end emerges from the trocar via the distal orifice thereof.


The push is continued until the prosthesis has deployed completely outside the trocar. It may be possible to use forceps to pull on the distal end of the prosthesis, or to use a pusher to continue pushing the prosthesis in the trocar.


In this application, the distal end of a device means the end farthest from the hand of the user, and the proximal end means the end nearest to the hand of the user. Likewise in this application, the term “distal direction” means the direction of introduction of the prosthesis into the body of the patient, and the term “proximal direction” means the direction opposite to this direction of introduction.


By virtue of the structure of the prosthesis according to the invention, the step of introducing the bend into the trocar is greatly facilitated. Likewise, with the prosthesis made perfectly compact, it passes through the trocar easily and without damage.


Finally, the automatic return of the frame to its initial configuration brings about the automatic deployment of the prosthesis and the perfect spreading-out of the latter at the implantation site.





The advantages of the present invention will become clearer from the following detailed description and from the attached drawings in which:



FIG. 1 shows a plan view of a first embodiment of a prosthesis according to the invention,



FIG. 2 shows a perspective view of one end of the prosthesis from FIG. 1, when the prosthesis is in the compact shape,



FIG. 3 shows the step of introducing one end of the prosthesis from FIG. 2 into the proximal orifice of a trocar,



FIG. 4 is a side view of the prosthesis from FIG. 1 in the compact shape and partially introduced into the trocar from FIG. 3,



FIG. 5 is a side view of the prosthesis from FIG. 1 in the compact shape and partially emerging from the trocar of FIG. 3,



FIG. 6 is a side view showing the automatic deployment of the prosthesis from FIG. 1 when it has emerged almost completely from the trocar of FIG. 3,



FIG. 7 is a plan view of a second embodiment of the prosthesis according to the invention.






FIG. 1 shows an embodiment of a prosthesis 1 according to the invention. The prosthesis 1 comprises a biocompatible textile 2 and a reinforcing element in the form of a frame 3.


As will be clear from FIG. 1, the textile 2 has a generally elongate shape defining a longitudinal axis A. The textile 2 is thus delimited by a peripheral outer edge 2a forming substantially two opposite long sides 2b, which are substantially parallel to the longitudinal axis A, and two opposite short sides 2c, which are substantially perpendicular to the longitudinal axis A. In the example shown, the textile 2 has the general shape of an ellipse. Such a shape is suitable for the repair of a hernia of the abdominal wall, for example.


In other embodiments, the textile 2 could have an oval shape or a rectangular shape or could be protean if the shape in question is generally elongate and defines a longitudinal axis.


The textile 2 is made up of an arrangement of biocompatible filaments, such as a knit, a woven or a nonwoven. Preferably, as is shown in FIG. 1, the textile 2 is in the form of a mesh, that is to say it has openings for better tissue integration. For example, the textile 1 can be a two-dimensional or three-dimensional knit. Such textiles in the form of meshes or knits are well known to a person skilled in the art and are not described in any greater detail here.


The textile 2 can be bioresorbable, permanent or partially bioresorbable. As will become clear from the description below, the textile 2 is sufficiently flexible to be folded up, in particular at the time of introduction of the prosthesis into a trocar, along one or more longitudinal folds. In general, however, the textile 2 does not have an inherent elasticity allowing it to spontaneously recover a spread-out configuration once it has been folded up. The textile 2 can be supplied in the form of a band, which one cuts to the dimensions of the defect to be treated.


Referring again to FIG. 1, and as will become clear on reading the description below, the frame 3 acts as an element reinforcing the textile 2 in order to stiffen the latter and keep it in its generally elongate shape, as a tool for guiding the prosthesis 1 at the time of its introduction into a trocar, and as a tool for assisting in the deployment of the prosthesis when the latter emerges from the trocar at the implantation site. For this purpose, the frame 3 is connected to the textile 2 and has an elasticity allowing it to be deformed under the effect of a temporary stress and allowing it to return to an initial state of rest once said stress has been removed.


The frame 3 is connected to the textile 2. It can be attached to the textile 2 by means of a seam, or else by means of an ultrasonic weld, by adhesive bonding, or by injection moulding.


In one embodiment, the frame 3 is connected to the textile 2 by injection moulding of one or more thermoplastic or thermosetting biocompatible materials. Such an embodiment makes it possible to secure the fixing of the frame to the textile in a particularly effective manner and to produce the prostheses according to the invention at an industrial scale.


In the injection moulding technique, a mould is formed in which, for example, there is a cavity defining a contour which corresponds to the contour of the frame that is to be obtained, namely a generally elliptical contour as regards the example shown in FIGS. 1 and 2. The textile is held in an insert gate of the mould. The thermoplastic material used to produce the frame, for example a copolymer of polylactic acid and of polyglycolic acid, is heated and injected into the cavity using an injection moulding machine.


After the injection step, the mould is opened and the prosthesis 1 is withdrawn from the mould. Such a method allows the textile to be “embedded” in the part moulded over it. Thus, the frame 3, which is the overmoulded part, is connected to the textile, without any risk of its coming loose or fragmenting.


The frame 3 is continuous. Thus, as will become clear from the description below, the step of pressing the prosthesis together, by pressing the frame together towards the longitudinal axis of the prosthesis, does not create any projecting elements that could potentially perforate and damage the tissues. By virtue of its nature and its shape, the frame only has rounded and atraumatic outer contours.


In particular, the frame 3 has a structure, in other words a shape, and a nature, in other words a material, giving it an elasticity such that it is able to adopt a first, unstressed configuration in which its shape follows substantially the contour of the peripheral outer edge and in which the textile 2 and the prosthesis 1 are deployed and spread out as shown in FIG. 1, and a second, stressed configuration in which its two long sides 3b are brought towards the central longitudinal axis of the textile 2, as shown in FIG. 2, and the prosthesis 1 has a compact shape in its radial direction.


Thus, in the example shown in FIG. 1, the frame 3, in its unstressed configuration, has substantially the shape of an ellipse, with two opposite long sides 3b, which are substantially parallel to the longitudinal axis A, and two opposite short sides 3c, which are substantially perpendicular to the longitudinal axis A. In the area of each of its short sides 3c, the frame 3 forms a U-shaped bend 4 extending, in the direction of the longitudinal axis A, towards the outside of the frame 3. Thus, the frame 3 follows substantially the outer edge of the textile, being slightly set back from this edge.


Alternatively, in an embodiment not shown, in which the textile has a rectangular shape with two opposite long sides and two opposite short sides, the shape of the frame follows the contour of the outer edge of the textile and likewise describes a rectangle with two opposite long sides and two opposite short sides, each of its opposite short sides being provided with a bend extending towards the outside of the frame or alternatively towards the inside of the frame.


On account of the nature and the structure of the frame 3, the U-shaped bends 4 act as guides for introducing the prosthesis 1 into a small orifice, such as an admission orifice of a trocar, when the frame 3 is in its stressed configuration. Indeed, when the user, for example using his hand, exerts a radial pressure on the opposite long sides of the frame 3 towards the longitudinal axis of the prosthesis 1, the resulting deformation of the frame 3 projects the U-shaped bends 4 towards the outside of the frame, as is shown in FIG. 3, the two opposite bends 4 remaining aligned on the longitudinal axis A.


Thus, in order to easily introduce the prosthesis 1 from FIG. 1 into a trocar, the user uses his hand 10 to exert the above-described radial pressure on the long sides 3b of the frame 3, as has been described with reference to FIG. 2, placing to the front, at each end of the prosthesis, the corresponding U-shaped bend 4. The prosthesis 1 then has a compact configuration in its radial part, substantially aligned on the longitudinal axis A of the textile 2 which forms at least one longitudinal fold. Depending on how the prosthesis 1 is folded and/or on the degree of stress applied to the frame 3, the textile 2 can form several longitudinal folds, like an accordion.


The user then takes hold of a trocar 5 into which he wishes to introduce the prosthesis 1. He brings the U-shaped bend 4, situated in the distal position and forming a guide element, towards the proximal orifice 5a of the trocar 5 and introduces it into the trocar 5. By virtue of its structure and its nature, the U-shaped bend 4 is sufficiently rigid to easily enter the conduit of the trocar 5 and to continue advancing under the effect of a distal push exerted by the user, as is shown in FIG. 3.


By virtue of its elongate compact shape, and the rigidity conferred on it by the presence of the frame 3, the prosthesis 1 also easily enters the conduit of the trocar 5, until the first U-shaped bend 4 of the frame 3 appears through the distal orifice 5b of the trocar, bringing with it the textile 2 to which it is connected, as is shown in FIG. 4.


The user continues to exert a distal push on the prosthesis 1, in particular on the frame 3 and on the proximally situated U-shaped bend 4 thereof which stiffens the prosthesis 1. As is shown in FIG. 5, as a larger part of the textile 2 of the prosthesis 1 gradually escapes from the stresses of the walls of the trocar 5, the frame 3 returns little by little to its initial state of rest and causes the automatic deployment of the textile 2 and, therefore, of the prosthesis 1. When the prosthesis 1 has emerged almost completely from the trocar 5, as is shown in FIG. 6, the frame 3 has practically recovered its ellipse shape corresponding to its unstressed configuration, and the textile 2 and therefore the prosthesis 1 are perfectly deployed and spread out.


The prosthesis 1 is then ready to be positioned opposite a hernia defect to be treated, without any risk of folds forming in the textile 2. The risks of adherence or insertion of surrounding organs in such folds are thus very much limited.



FIG. 7 shows another embodiment of the prosthesis 1 according to the invention, in which the textile 2 and the frame 3 also generally have the shape of an ellipse. However, in the example shown in this figure, the frame 3 forms a bend 6 which, in the direction of the longitudinal axis A, extends towards the inside of the frame 3, in the area of each of the short sides 3c thereof. Moreover, in the area of each of its long sides 3b, the frame 3 forms a supplementary bend 8, which extends towards the inside of the frame 3 in a direction perpendicular to the longitudinal axis A.


The presence of the bends 6 and of the supplementary bends 8 gives the frame 3 increased elasticity in the direction perpendicular to the longitudinal axis A. Such a shape of the frame 3 makes it possible to easily press the prosthesis 1 together and align it on the longitudinal axis A in the stressed configuration of the frame 3. Since the bends 6 on the short sides 3c extend towards the inside of the frame 3, the step of pressing together causes the formation of two stubs 7 on the frame 3 at each end of the prosthesis 1, these two stubs 7 acting as guide elements for the prosthesis 1 and making it easier to introduce the latter into the trocar, as has been explained above for the embodiment in FIG. 1.


The prosthesis according to the invention can thus be easily introduced into a trocar, without requiring the help of an additional tool, and without any risk of forming a plug inside the trocar. By virtue of its nature and its structure, the frame of the prosthesis according to the invention acts as a reinforcing element for the textile and stiffens the prosthesis, as an element for guiding and transporting the prosthesis inside a trocar conduit of particularly small diameter, such as a diameter of 5-15 mm, and also as a tool for assisting in the automatic and perfect spreading-out of the prosthesis at the moment when the latter emerges from the trocar at the implantation site.

Claims
  • 1. A prosthesis comprising: at least one biocompatible textile of generally elliptic shape defining a medial longitudinal axis, the biocompatible textile being delimited by a peripheral outer edge forming substantially two opposite long sides and two opposite short sides, andat least one reinforcing element for the biocompatible textile, wherein the reinforcing element is in the form of a continuous resilient generally elliptical frame connected to the biocompatible textile, the frame following substantially the peripheral outer edge of the biocompatible textile, being set back from the peripheral outer edge of the biocompatible textile, the frame including at least one U-shaped bend extending towards an inside of the frame in a direction of the medial longitudinal axis in an area of each of the two opposite short sides of the biocompatible textile, and at least one supplementary bend extending towards an inside of the frame in a direction perpendicular to the medial longitudinal axis and in an area of each of the two opposite long sides of the biocompatible textile, the at least one supplementary bend positioned between a proximal portion and a distal portion of the frame, the proximal and distal portions of the frame extending along a length of the peripheral outer edge and parallel to the peripheral outer edge, the length of each of the proximal and distal portions being greater than a length the at least one supplementary bend extends along the peripheral outer edge.
  • 2. The prosthesis according to claim 1, wherein the proximal portions of the frame, in each of the two opposite long sides, are connected to each other by the at least one U-shaped bend on a first short side of the two opposite short sides, and the distal portions of the frame, in each of the two opposite long sides, are connected to each other by the at least one U-shaped bend on a second short side of the two opposite short sides.
  • 3. The prosthesis according to claim 1, wherein the frame forms two stubs, at each end of the prosthesis, acting as guide elements for the prosthesis when folded over the medial longitudinal axis and configured to facilitate introduction of the prosthesis into a trocar.
  • 4. The prosthesis according to claim 1, wherein the reinforcing element is injection molded on the biocompatible textile.
  • 5. The prosthesis according to claim 1, wherein the reinforcing element comprises a bioresorbable material.
  • 6. The prosthesis according to claim 5, wherein the bioresorbable material is selected from the group consisting of polylactic acid, polycaprolactone, polydioxanones, trimethylene carbonates, polyvinyl alcohols, polyhydroxyalkanoates, oxidized cellulose, polyglycolic acid, and mixtures thereof.
  • 7. The prosthesis according to claim 1, wherein the reinforcing element comprises a copolymer of polylactic acid and polyglycolic acid.
  • 8. The prosthesis according to claim 1, wherein the reinforcing element comprises a non-bioresorbable material.
  • 9. The prosthesis according to claim 8, wherein the non-bioresorbable material is selected from the group consisting of polypropylenes, polyethylene terephthalates, polyamides, silicones, polyether ether ketones, polyarylether ether ketones, polyurethanes, and mixtures thereof.
  • 10. The prosthesis according to claim 1, wherein the biocompatible textile is a two-dimensional knit mesh.
  • 11. The prosthesis according to claim 1, wherein the biocompatible textile is a three-dimensional knit mesh.
  • 12. The prosthesis according to claim 1, wherein one face of the biocompatible textile comprises a non-stick coating.
  • 13. The prosthesis of claim 1, wherein the frame is configured to adopt an unstressed configuration, in which the biocompatible textile is deployed, and a stressed configuration, in which the frame is subjected to a radial force directed over the medial longitudinal axis and the biocompatible textile forms at least one longitudinal fold.
  • 14. A method of conveying a prosthesis to an implantation site comprising: providing a prosthesis including at least one flexible biocompatible textile of generally elliptical shape defining a medial longitudinal axis, the biocompatible textile being delimited by a peripheral outer edge forming substantially two opposite long sides and two opposite short sides, and at least one reinforcing element for the biocompatible textile, wherein the reinforcing element is in the form of a continuous resilient generally elliptical frame connected to the biocompatible textile, the frame following substantially the peripheral outer edge of the biocompatible textile, being set back from the peripheral outer edge of the biocompatible textile, the frame including at least one U-shaped bend extending towards an inside of the frame in a direction of the medial longitudinal axis in an area of each of the two opposite short sides of the biocompatible textile, and at least one supplementary bend extending towards an inside of the frame in a direction perpendicular to the medial longitudinal axis and in an area of each of the two opposite long sides of the biocompatible textile, the at least one supplementary bend positioned between a proximal portion and a distal portion of the frame, the proximal and distal portions of the frame extending along a length of the peripheral outer edge and parallel to the peripheral outer edge, the length of each of the proximal and distal portions being greater than a length the at least one supplementary bend extends along the peripheral outer edge,folding the two opposite long sides of the biocompatible textile over the medial longitudinal axis via the at least one U-shaped bend, in each of the two opposite short sides, to place the biocompatible textile in a stressed configuration and forming two stubs acting as guide elements for the prosthesis,introducing the biocompatible textile in the stressed configuration into a proximal orifice of a trocar via the stubs formed with the U-shaped bends, andpassing the biocompatible textile through a distal orifice of the trocar to the site of implantation wherein the biocompatible textile automatically unfolds from the stressed configuration to an unstressed configuration.
  • 15. The method of claim 14, wherein the two stubs are formed at each end of the prosthesis and configured to facilitate introduction of the prosthesis into the trocar.
  • 16. A prosthesis comprising: at least one biocompatible textile of generally elliptic shape defining a medial longitudinal axis, the biocompatible textile being delimited by a peripheral outer edge forming substantially two opposite long sides and two opposite short sides, andat least one reinforcing element for the biocompatible textile, wherein the reinforcing element is in the form of a continuous resilient generally elliptical frame connected to the biocompatible textile and being set back from the peripheral outer edge of the biocompatible textile, the frame following substantially the peripheral outer edge of the biocompatible textile and including at least one U-shaped bend extending along the medial longitudinal axis towards a center of the medial longitudinal axis and in an area of at least one of the two opposite short sides, and at least one supplementary bend extending towards an inside of the frame in a direction perpendicular to the medial longitudinal axis and in an area of at least one of the two opposite long sides of the biocompatible textile, wherein the generally elliptical frame set back from and following substantially the peripheral outer edge includes portions extending parallel to the peripheral outer edge, the portions extending along a length of the peripheral outer edge, the length of each portion being greater than a length of the at least one supplementary bend extends along the peripheral outer edge.
Priority Claims (1)
Number Date Country Kind
FR13/55258 Jun 2013 FR national
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 14/784,058 filed on Oct. 13, 2015, which is a National Stage Application of PCT/EP2014/061654 filed Jun. 5, 2014, which claims the benefit of and priority to French Patent Application Serial No. 13/55258 filed on Jun. 7, 2013, the disclosures of each of the above-identified applications are hereby incorporated by reference in their entirety.

US Referenced Citations (328)
Number Name Date Kind
1187158 Mcginley Jun 1916 A
3118294 Van Laethem Jan 1964 A
3124136 Usher Mar 1964 A
3272204 Artandi et al. Sep 1966 A
3276448 Kronenthal Oct 1966 A
3320649 Naimer May 1967 A
3364200 Ashton et al. Jan 1968 A
3570482 Shigeru et al. Mar 1971 A
4006747 Kronenthal et al. Feb 1977 A
4060081 Yannas et al. Nov 1977 A
4173131 Melton et al. Nov 1979 A
4193137 Heck Mar 1980 A
4248064 Odham Feb 1981 A
4294241 Miyata Oct 1981 A
4307717 Hymes et al. Dec 1981 A
4338800 Matsuda Jul 1982 A
4476697 Schäfer et al. Oct 1984 A
4487865 Balazs et al. Dec 1984 A
4500676 Balazs et al. Feb 1985 A
4511653 Play et al. Apr 1985 A
4527404 Nakagaki et al. Jul 1985 A
4591501 Cioca May 1986 A
4597762 Walter et al. Jul 1986 A
4603695 Ikada et al. Aug 1986 A
4631932 Sommers Dec 1986 A
4670014 Hue et al. Jun 1987 A
4709562 Matsuda Dec 1987 A
4748078 Doi et al. May 1988 A
4759354 Quarfoot Jul 1988 A
4769038 Bendavid et al. Sep 1988 A
4796603 Dahlke et al. Jan 1989 A
4813942 Alvarez Mar 1989 A
4841962 Berg et al. Jun 1989 A
4854316 Davis Aug 1989 A
4925294 Geshwind et al. May 1990 A
4931546 Tardy et al. Jun 1990 A
4942875 Hlavacek et al. Jul 1990 A
4948540 Nigam Aug 1990 A
4950483 Ksander et al. Aug 1990 A
4970298 Silver et al. Nov 1990 A
5002551 Linsky et al. Mar 1991 A
5147374 Fernandez Sep 1992 A
5162430 Rhee et al. Nov 1992 A
5171273 Silver et al. Dec 1992 A
5176692 Wilk et al. Jan 1993 A
5192301 Kamiya et al. Mar 1993 A
5196185 Silver et al. Mar 1993 A
5201745 Tayot et al. Apr 1993 A
5201764 Kelman et al. Apr 1993 A
5206028 Li Apr 1993 A
5217493 Raad et al. Jun 1993 A
5254133 Seid Oct 1993 A
5256418 Kemp et al. Oct 1993 A
5263983 Yoshizato et al. Nov 1993 A
5304595 Rhee et al. Apr 1994 A
5306500 Rhee et al. Apr 1994 A
5324775 Rhee et al. Jun 1994 A
5328955 Rhee et al. Jul 1994 A
5334527 Brysk Aug 1994 A
5339657 Mcmurray Aug 1994 A
5350583 Yoshizato et al. Sep 1994 A
5356432 Rutkow et al. Oct 1994 A
5368549 Mcvicker Nov 1994 A
5376375 Rhee et al. Dec 1994 A
5376376 Li Dec 1994 A
5397331 Himpens et al. Mar 1995 A
5399361 Song et al. Mar 1995 A
5413791 Rhee et al. May 1995 A
5425740 Hutchinson, Jr. Jun 1995 A
5428022 Palefsky et al. Jun 1995 A
5433996 Kranzler et al. Jul 1995 A
5441491 Verschoor et al. Aug 1995 A
5441508 Gazielly et al. Aug 1995 A
5456693 Conston et al. Oct 1995 A
5456711 Hudson Oct 1995 A
5466462 Rosenthal et al. Nov 1995 A
5480644 Freed Jan 1996 A
5487895 Dapper et al. Jan 1996 A
5490984 Freed Feb 1996 A
5512291 Li Apr 1996 A
5512301 Song et al. Apr 1996 A
5514181 Light et al. May 1996 A
5522840 Krajicek Jun 1996 A
5523348 Rhee et al. Jun 1996 A
5536656 Kemp et al. Jul 1996 A
5543441 Rhee et al. Aug 1996 A
5565210 Rosenthal et al. Oct 1996 A
5567806 Abdul-Malak et al. Oct 1996 A
5569273 Titone et al. Oct 1996 A
RE35399 Eisenberg Dec 1996 E
5593441 Lichtenstein et al. Jan 1997 A
5595621 Light et al. Jan 1997 A
5601571 Moss Feb 1997 A
5607474 Athanasiou et al. Mar 1997 A
5607590 Shimizu Mar 1997 A
5614587 Rhee et al. Mar 1997 A
5618551 Tardy et al. Apr 1997 A
5634931 Kugel Jun 1997 A
5639796 Lee Jun 1997 A
5665391 Lea Sep 1997 A
5667839 Berg Sep 1997 A
5681568 Goldin et al. Oct 1997 A
5686115 Vournakis et al. Nov 1997 A
5690675 Sawyer et al. Nov 1997 A
5695525 Mulhauser et al. Dec 1997 A
5697978 Sgro Dec 1997 A
5700476 Rosenthal et al. Dec 1997 A
5700477 Rosenthal et al. Dec 1997 A
5709934 Bell et al. Jan 1998 A
5716409 Debbas Feb 1998 A
5720981 Eisinger Feb 1998 A
5732572 Litton Mar 1998 A
5749895 Sawyer et al. May 1998 A
5752974 Rhee et al. May 1998 A
5766246 Mulhauser et al. Jun 1998 A
5766631 Arnold Jun 1998 A
5769864 Kugel Jun 1998 A
5771716 Schlussel Jun 1998 A
5785983 Furlan et al. Jul 1998 A
5800541 Rhee et al. Sep 1998 A
5814328 Gunasekaran Sep 1998 A
5833705 Ken et al. Nov 1998 A
5840011 Landgrebe et al. Nov 1998 A
5861034 Taira et al. Jan 1999 A
5863984 Doillon et al. Jan 1999 A
5869080 Mcgregor et al. Feb 1999 A
5871767 Dionne et al. Feb 1999 A
5876444 Lai Mar 1999 A
5891558 Bell et al. Apr 1999 A
5899909 Claren et al. May 1999 A
5906937 Sugiyama et al. May 1999 A
5910149 Kuzmak Jun 1999 A
5911731 Pham et al. Jun 1999 A
5916225 Kugel Jun 1999 A
5919232 Chaffringeon et al. Jul 1999 A
5919233 Knopf et al. Jul 1999 A
5922026 Chin Jul 1999 A
5931165 Reich et al. Aug 1999 A
5942278 Hagedorn et al. Aug 1999 A
5962136 Dewez et al. Oct 1999 A
5972022 Huxel Oct 1999 A
RE36370 Li Nov 1999 E
5993844 Abraham et al. Nov 1999 A
5994325 Roufa et al. Nov 1999 A
5997895 Narotam et al. Dec 1999 A
6001895 Harvey et al. Dec 1999 A
6008292 Lee et al. Dec 1999 A
6015844 Harvey et al. Jan 2000 A
6039686 Robert Mar 2000 A
6042534 Gellman et al. Mar 2000 A
6042592 Schmitt Mar 2000 A
6043089 Sugiyama et al. Mar 2000 A
6051425 Morota et al. Apr 2000 A
6056688 Benderev et al. May 2000 A
6056970 Greenawalt et al. May 2000 A
6057148 Sugiyama et al. May 2000 A
6063396 Kelleher May 2000 A
6066776 Goodwin et al. May 2000 A
6066777 Benchetrit May 2000 A
6071292 Makower et al. Jun 2000 A
6077281 Das Jun 2000 A
6080194 Pachence et al. Jun 2000 A
6083522 Chu et al. Jul 2000 A
6120539 Eldridge et al. Sep 2000 A
6132765 Dicosmo et al. Oct 2000 A
6143037 Goldstein et al. Nov 2000 A
6153292 Bell et al. Nov 2000 A
6165488 Tardy et al. Dec 2000 A
6171318 Kugel et al. Jan 2001 B1
6174320 Kugel et al. Jan 2001 B1
6176863 Kugel et al. Jan 2001 B1
6179872 Bell et al. Jan 2001 B1
6197325 Macphee et al. Mar 2001 B1
6197934 Devore et al. Mar 2001 B1
6197935 Doillon et al. Mar 2001 B1
6210439 Firmin et al. Apr 2001 B1
6221109 Geistlich et al. Apr 2001 B1
6224616 Kugel May 2001 B1
6241768 Agarwal et al. Jun 2001 B1
6258124 Darois et al. Jul 2001 B1
6262332 Ketharanathan Jul 2001 B1
6264702 Ory et al. Jul 2001 B1
6267772 Mulhauser et al. Jul 2001 B1
6277397 Shimizu Aug 2001 B1
6280453 Kugel et al. Aug 2001 B1
6287316 Agarwal et al. Sep 2001 B1
6290708 Kugel et al. Sep 2001 B1
6306424 Vyakarnam et al. Oct 2001 B1
6312474 Francis et al. Nov 2001 B1
6328686 Robert Dec 2001 B1
6334872 Termin et al. Jan 2002 B1
6383201 Dong May 2002 B1
6391333 Li et al. May 2002 B1
6391939 Tayot et al. May 2002 B2
6408656 Ory et al. Jun 2002 B1
6410044 Chudzik et al. Jun 2002 B1
6413742 Olsen et al. Jul 2002 B1
6428978 Olsen et al. Aug 2002 B1
6436030 Rehil Aug 2002 B2
6440167 Shimizu Aug 2002 B2
6443964 Ory et al. Sep 2002 B1
6447551 Goldmann Sep 2002 B1
6447802 Sessions et al. Sep 2002 B2
6448378 Devore et al. Sep 2002 B2
6451032 Ory et al. Sep 2002 B1
6451301 Sessions et al. Sep 2002 B1
6454787 Maddalo et al. Sep 2002 B1
6477865 Matsumoto Nov 2002 B1
6479072 Morgan et al. Nov 2002 B1
6500464 Ceres et al. Dec 2002 B2
6509031 Miller et al. Jan 2003 B1
6511958 Atkinson et al. Jan 2003 B1
6514286 Leatherbury et al. Feb 2003 B1
6514514 Atkinson et al. Feb 2003 B1
6540773 Dong Apr 2003 B2
6541023 Andre et al. Apr 2003 B1
6548077 Gunasekaran Apr 2003 B1
6554855 Dong Apr 2003 B1
6559119 Burgess et al. May 2003 B1
6566345 Miller et al. May 2003 B2
6575988 Rousseau Jun 2003 B2
6576019 Atala Jun 2003 B1
6596002 Therin et al. Jul 2003 B2
6596304 Bayon et al. Jul 2003 B1
6599323 Melican et al. Jul 2003 B2
6599524 Li et al. Jul 2003 B2
6599690 Abraham et al. Jul 2003 B1
6613348 Jain Sep 2003 B1
6623963 Mueller et al. Sep 2003 B1
6630414 Matsumoto Oct 2003 B1
6638284 Rousseau et al. Oct 2003 B1
6652594 Francis et al. Nov 2003 B2
6652595 Nicolo Nov 2003 B1
6653450 Berg et al. Nov 2003 B1
6656206 Corcoran et al. Dec 2003 B2
6660280 Allard et al. Dec 2003 B1
6669735 Pelissier Dec 2003 B1
6682760 Noff et al. Jan 2004 B2
6685714 Rousseau Feb 2004 B2
6706684 Bayon et al. Mar 2004 B1
6706690 Reich et al. Mar 2004 B2
6719795 Bryan et al. Apr 2004 B1
6723335 Moehlenbruck et al. Apr 2004 B1
6730299 Tayot et al. May 2004 B1
6736823 Darois et al. May 2004 B2
6743435 Devore et al. Jun 2004 B2
6755868 Rousseau Jun 2004 B2
6773723 Spiro et al. Aug 2004 B1
6783554 Amara et al. Aug 2004 B2
6790213 Cherok et al. Sep 2004 B2
6790454 Abdul et al. Sep 2004 B1
6800082 Rousseau Oct 2004 B2
6833408 Sehl et al. Dec 2004 B2
6835336 Watt Dec 2004 B2
6852330 Bowman et al. Feb 2005 B2
6869938 Schwartz et al. Mar 2005 B1
6893653 Abraham et al. May 2005 B2
6896904 Spiro et al. May 2005 B2
6936276 Spiro et al. Aug 2005 B2
6939562 Spiro et al. Sep 2005 B2
6949625 Tayot Sep 2005 B2
6966918 Schuldt-Hempe et al. Nov 2005 B1
6971252 Therin et al. Dec 2005 B2
6974679 Andre et al. Dec 2005 B2
6974862 Ringeisen et al. Dec 2005 B2
6977231 Matsuda Dec 2005 B1
6988386 Okawa et al. Jan 2006 B1
7025063 Snitkin et al. Apr 2006 B2
7041868 Greene et al. May 2006 B2
RE39172 Bayon et al. Jul 2006 E
7098315 Schaufler Aug 2006 B2
7101381 Ford et al. Sep 2006 B2
7115220 Dubson et al. Oct 2006 B2
7156858 Schuldt-Hempe et al. Jan 2007 B2
7175852 Simmoteit et al. Feb 2007 B2
7192604 Brown et al. Mar 2007 B2
7207962 Anand et al. Apr 2007 B2
7214765 Ringeisen et al. May 2007 B2
7226611 Yura et al. Jun 2007 B2
7229453 Anderson et al. Jun 2007 B2
7594921 Browning Sep 2009 B2
7615065 Priewe et al. Nov 2009 B2
7670380 Cauthen, III et al. Mar 2010 B2
7709017 Tayot et al. May 2010 B2
7718556 Matsuda et al. May 2010 B2
7732354 Fricke et al. Jun 2010 B2
7785334 Ford et al. Aug 2010 B2
7799767 Lamberti et al. Sep 2010 B2
7806905 Ford et al. Oct 2010 B2
7824420 Eldridge et al. Nov 2010 B2
8142515 Therin et al. Mar 2012 B2
8197837 Jamiolkowski et al. Jun 2012 B2
8323675 Greenawalt Dec 2012 B2
8366787 Brown et al. Feb 2013 B2
8709094 Stad et al. Apr 2014 B2
8846060 Archibald et al. Sep 2014 B2
8877233 Obermiller et al. Nov 2014 B2
8956373 Ford et al. Feb 2015 B2
9034357 Stopek May 2015 B2
20020095218 Carr et al. Jul 2002 A1
20030086975 Ringeisen May 2003 A1
20030114937 Leatherbury et al. Jun 2003 A1
20030130745 Cherok et al. Jul 2003 A1
20030133967 Ruszczak et al. Jul 2003 A1
20030225355 Butler Dec 2003 A1
20040034373 Schuldt-Hempe et al. Feb 2004 A1
20040059356 Gingras Mar 2004 A1
20040101546 Gorman et al. May 2004 A1
20050002893 Goldmann Jan 2005 A1
20050021058 Negro Jan 2005 A1
20050085924 Darois et al. Apr 2005 A1
20050113849 Popadiuk et al. May 2005 A1
20050137512 Campbell et al. Jun 2005 A1
20050142161 Freeman et al. Jun 2005 A1
20050148963 Brennan Jul 2005 A1
20050175659 Macomber et al. Aug 2005 A1
20050232979 Shoshan Oct 2005 A1
20050267521 Forsberg Dec 2005 A1
20050288691 Leiboff Dec 2005 A1
20060064175 Pelissier et al. Mar 2006 A1
20060135921 Wiercinski et al. Jun 2006 A1
20060147501 Hillas et al. Jul 2006 A1
20060216320 Kitazono et al. Sep 2006 A1
20060252981 Matsuda et al. Nov 2006 A1
20070265710 Brown et al. Nov 2007 A1
20070299538 Roeber Dec 2007 A1
20100189764 Thomas et al. Jul 2010 A1
20120010636 Boey et al. Jan 2012 A1
Foreign Referenced Citations (98)
Number Date Country
1317836 May 1993 CA
19544162 Apr 1997 DE
10019604 Oct 2001 DE
10043396 Jun 2002 DE
0194192 Sep 1986 EP
0248544 Dec 1987 EP
0276890 Aug 1988 EP
0372969 Jun 1990 EP
0544485 Jun 1993 EP
0552576 Jul 1993 EP
0614650 Sep 1994 EP
0621014 Oct 1994 EP
0625891 Nov 1994 EP
0637452 Feb 1995 EP
0705878 Apr 1996 EP
0719527 Jul 1996 EP
0774240 May 1997 EP
0797962 Oct 1997 EP
0827724 Mar 1998 EP
0836838 Apr 1998 EP
0895762 Feb 1999 EP
0898944 Mar 1999 EP
1017415 Jul 2000 EP
1052319 Nov 2000 EP
1055757 Nov 2000 EP
1216717 Jun 2002 EP
1216718 Jun 2002 EP
0693523 Nov 2002 EP
1315468 Jun 2003 EP
1382728 Jan 2004 EP
1484070 Dec 2004 EP
1561480 Aug 2005 EP
1782848 May 2007 EP
2244853 Apr 1975 FR
2257262 Aug 1975 FR
2308349 Nov 1976 FR
2453231 Oct 1980 FR
2715405 Jul 1995 FR
2724563 Mar 1996 FR
2744906 Aug 1997 FR
2766698 Feb 1999 FR
2771622 Jun 1999 FR
2779937 Dec 1999 FR
2859624 Mar 2005 FR
2863277 Jun 2005 FR
2884706 Oct 2006 FR
2051153 Jan 1981 GB
H0332677 Feb 1991 JP
H05237128 Sep 1993 JP
H09137380 May 1997 JP
8902445 Mar 1989 WO
8908467 Sep 1989 WO
9012551 Nov 1990 WO
9206639 Apr 1992 WO
9220349 Nov 1992 WO
9311805 Jun 1993 WO
9318174 Sep 1993 WO
9417747 Aug 1994 WO
9507666 Mar 1995 WO
9518638 Jul 1995 WO
9532687 Dec 1995 WO
9603091 Feb 1996 WO
9608277 Mar 1996 WO
9609795 Apr 1996 WO
9614805 May 1996 WO
9641588 Dec 1996 WO
9735533 Oct 1997 WO
9835632 Aug 1998 WO
9849967 Nov 1998 WO
9905990 Feb 1999 WO
9906079 Feb 1999 WO
9906080 Feb 1999 WO
9951163 Oct 1999 WO
0016821 Mar 2000 WO
0067663 Nov 2000 WO
0115625 Mar 2001 WO
0180773 Nov 2001 WO
0207648 Jan 2002 WO
0222047 Mar 2002 WO
02078568 Oct 2002 WO
03002168 Jan 2003 WO
2004004600 Jan 2004 WO
2004071349 Aug 2004 WO
2004078120 Sep 2004 WO
2004103212 Dec 2004 WO
2005011280 Feb 2005 WO
2005013863 Feb 2005 WO
2005018698 Mar 2005 WO
2005105172 Nov 2005 WO
2006018552 Feb 2006 WO
2006023444 Mar 2006 WO
2007048099 Apr 2007 WO
2009031035 Mar 2009 WO
2009071998 Jun 2009 WO
2009126476 Oct 2009 WO
2011042553 Apr 2011 WO
2013007534 Jan 2013 WO
2013017836 Feb 2013 WO
Non-Patent Literature Citations (35)
Entry
Amid, P., “Lichtenstein tension-free hernioplasty: Its inception, evolution, and principles,” Hernia, 2004; pp. 1-7, 8, published online Sep. 2003.
Australian Examination Report for application No. 2014278850 dated Jul. 27, 2018 (5 pages).
Blondin, C. et al., “Inhibition of Complement Activation by Natural Sulfated Polysaccharides (Fucans) from Brown Seaweed,” Molecular Immuol., Mar. 1994, pp. 247-253, 31(4).
Blondin, C. et al., “Relationships between chemical characteristics and anticomplementary activity of fucans,” Biomaterials, Mar. 1996, pp. 597-603, 17(6).
Boisson-Vidal, C. et al., “Neoangiogenesis Induced by Progenitor Endothelial Cells: Effect of Fucoidan From Marine Algae,” Cardiovascular & Hematological Agents in Medicinal Chem., Jan. 2007, pp. 67-77, 5(1).
Bracco, P. et al., “Comparison of polypropylene and polyethylene terephthalate (Dacron) meshes for abdominal wall hernia repair: A chemical and morphological study,” Hernia, 2005, pp. 51-55, 9 (1), published online Sep. 2004.
Collins, R. et al., “Use of collagen film as a dural substitute: Preliminary animal studies,” Journal of Biomedical Materials Research, Feb. 1991, pp. 267-276, vol. 25.
Communication pursuant to Article 94(3) EPC issued in European Patent Application No. 14729283.3 dated Feb. 15, 2019, 4 pages.
Ellouali, M. et al., “Antitumor Activity of Low Molecular Weight Fucans Extracted from Brown Seaweed Ascophyllum nodosum,” Anticancer Res., Nov.-Dec. 1993, pp. 2011-2020, 12 (6A).
Examination Report for Australian Application No. 2014276850 dated Mar. 9, 2018, 3 pages.
Haneji, K. et al., “Fucoidan extracted from Cladosiphon Okamuranus Tokida Induces Apoptosis of Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells,” Nutrition and Cancer, 2005, pp. 189-201, 52(2), published online Nov. 2009.
Haroun-Bouhedja, F. et al., “In Vitro Effects of Fucans on MDA-MB231 Tumor Cell Adhesion and Invasion,” Anticancer Res., Jul.-Aug. 2002, pp. 2285-2292, 22(4).
Haroun-Bouhedja, F. et al., “Relationship between sulfate groups and biological activities of fucans,” Thrombosis Res., Dec. 2000, pp. 453-459, 100(5).
Hirano, S. et al., “The blood biocompatibility of chitosan and N-acylchitosans,” J. Biomed. Mater. Res., Apr. 1985, 413-417, 19.
International Search Report for PCT/EP14/061654 date of completion is Jul. 9, 2014 (3 pages).
Junge, K. et al., “Functional and Morphologic Properties of a Modified Mesh for Inguinal Hernia Repair,” World J. Surg. Sep. 2002, pp. 1472-1480, 26.
Kanabar, V. et al., “Some structural determinants of the antiproliferative effect of heparin-like molecules on human airway smooth muscle,” Br. J. Pharmacol., Oct. 2005, pp. 370-777, 146(3).
Klinge, U. et al., “Foreign Body Reaction to Meshes Used for the Repair of Abdominal Wall Hernias,” Eur J. Surg, Sep. 1999, pp. 665-673, 165.
Klinge, U. et al., “Functional and Morphological Evaluation of a Low-Weight, Monofilament Polypropylene Mesh for Hernia Repair,” J Biomed. Mater. Res., Jan. 2002, pp. 129-136, 63.
Langenbech, M. R. et al., “Comparison of biomaterials in the early postoperative period,” Surg Endosc., May 2003, pp. 1105-1109, 17(7).
Logeart, D. et al., “Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. II. Degradation and molecular weight effect,” Eur. J. Cell. Biol., Dec. 1997, pp. 385-390, 74(4).
Malette, W. G. et al., “Chitosan, A New Hemostatic,” Ann Th. Surg., Jul. 1983, pp. 55-58, 36.
Muzzarelli, R. et al., “Reconstruction of parodontal tissue with chitosan,” Biomaterials, Nov. 1989, pp. 598-604, 10.
O'Dwyer, P. et al., “Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair,” Br. J. Surg., Feb. 2005, pp. 166-170, 92(2).
Preliminary Search Report from French Patent Office dated Dec. 20, 2006, 3 pages.
Prokop, A. et al., “Water Soluble Polymers for Immunoisolation I: Complex Coacevation and Cytotoxicity,” Advances in Polymer Science, Jul. 1998, pp. 1-51, 136.
Rao, B. et al., “Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential,” J. Biomed. Mater. Res., Jan. 1997, pp. 21-28, 34.
Rosen, M. et al., “Laparoscopic component separation in the single-stage treatment of infected abdominal wall prosthetic removal,” Hernia, 2007, pp. 435-440, 11, published online Jul. 2007.
Scheidbach, H. et al., “In vivo studies comparing the biocompatibility of various polypropylene meshes and their handling properties during endoscopic total extraperitoneal (TEP) patchplasty: An experimental study in pigs,” Surg. Endosc., Feb. 2004, pp. 211-220,18(2).
Strand, S. et al., “Screening of Chitosans and Conditions for Bacterial Flocculation,” Biomacromolecules, Mar. 2001, 126-133, 2.
Varum, K. et al., “In vitro degradation rates of partially N-acetylated chitosans in human serum,” Carbohydrate Research, Mar. 1997, pp. 99-101, 299.
Welty, G. et al., “Functional impairment and complaints following incisional hernia repair with different polypropylene meshes,” Hernia, Aug. 2001; pp. 142-147, 5.
Zvyagintseva, T. et al., “Inhibition of complement activation by water-soluble polysaccharides of some far-eastern brown seaweeds,” Comparative Biochem and Physiol, Jul. 2000, pp. 209-215,126(3).
Communication pursuant to Article 94(3) EPC issued in European Application No. 14729283.3 dated Mar. 4, 2021.
Communication pursuant to Article 94(3) EPC issued in European Patent Application No. 14729283.3 dated Feb. 7, 2022.
Related Publications (1)
Number Date Country
20190350691 A1 Nov 2019 US
Continuations (1)
Number Date Country
Parent 14784058 US
Child 16527458 US